Christine A. White

Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from 4 clinical trials.

Gregory A. Wiseman, Ellen Kornmehl, Bryan R. Leigh et al. · PubMed · 2003 · 216 citations

Medicine, Nuclear Medicine, Oncology +17

IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma

David G. Maloney, Antonio J Grillo-López, Christine A. White et al. · Blood · 1997 · 156 citations · Full text

Medicine, Hematology, Oncology +14

Radiation Dosimetry Results From a Phase II Trial of Ibritumomab Tiuxetan (Zevalin™) Radioimmunotherapy for Patients With Non-Hodgkin's Lymphoma and Mild Thrombocytopenia

Gregory A. Wiseman, Bryan R. Leigh, William D. Erwin et al. · Cancer Biotherapy and Radiopharmaceuticals · 2003 · 30 citations

Medicine, Hematology, Oncology +17

Additional Radiation Absorbed Dose Estimates for Zevalin™ Radioimmunotherapy

Gregory A. Wiseman, Bryan R. Leigh, William L. Dunn et al. · Cancer Biotherapy and Radiopharmaceuticals · 2003 · 24 citations

Medicine, Nuclear Medicine, Oncology +17

SOCS3 Deletion in B Cells Alters Cytokine Responses and Germinal Center Output

Sarah A. Jones, Christine A. White, Lorraine Robb et al. · The Journal of Immunology · 2011 · 20 citations · Full text

Life Sciences, Cell Biology, Immunology +17